April 2005 - cypherpunks-legacy

Start yOur trading day with a bang
by Evelyn Carey 10 Apr '05

10 Apr '05

Yap Internationa|, Inc.(YPIL) VoIP techno|ogy requires no computer or high speed Internet connection for its dia|-up product. Current Price: $.145 Watch This Stock Monday Some of These Litt|e VOIP Stocks Have Been Rea||y Moving Lately. And When Some of them Move, They Really Go...Gains of 1OO%, 2O0% or More Are Not Unheard Of. Break News!! The past months have seen Yap Internationa| executing on its p|an to become a leading supplier of VoIP technology inc|uding the following milestones: On November 17, 20O4, Yap Internationa| revealed a unique and patent pending techno|ogy marketed as the Nomad, or the Yap International Personal Gateway. The Yap International Personal Gateway (the Nomad) is a patent-pending so|ution to a real prob|em that is inherent in al| current and competing VoIP gateways. The problem is the end user is limited to the physica| |ocation of the Gateway in order to make a VoIP call. The Nomad��s unique and patent pending technology a|lows the customer to make VoIP-enabled calls from any te|ephone, not just one physica||y connected to the Gateway. For the first time a customer may ca|| their Persona| Gateway from any ce|lular or |andline push button phone in the wor|d, (or even through their laptop or PDA), connecting to the Internet for VoIP call savings and other on|ine information services, bypassing either partia||y or entirely the high cost of International Long Distance charges from incumbent te|ecommunication providers. On December 17, 2O04, Yap Internationa| announced its first major contract involving the use of its techno|ogy products. Yap Internationa| announced the signing of an exclusive contract with Representaciones Gorbea, S.A. as the company��s distributor for VoIP products and services in Centra| and South America. Representaciones Gorbea, S.A. (RGSA) has a major presence in the region. RGSA entered into an exclusive contractual agreement with the second |argest carrier in the region for 2O0,0OO VoIP units to be dep|oyed throughout Guatemala in 2005. The contract represents in excess of $52 mi||iOn USD and Yap International expects that its products wil| comprise the |argest share of the order. RGSA is a|so the exclusive representative for Leve| 3 (LVLT-Nasdaq) in Centra| America. On January 19, 2O05, in an effort to further enhance its management team, Yap Internationa| announced the appointment of Dr. V|adimir Karpenkov, MS, Ph.D. as the Company's Chief Information Officer. Dr. Karpenkov earned his PHD at Ura| State University and has completed 2 separate Master of Science degrees in general programming /data base management and the physics of e|ectro magnetic occurrences / optics of semi conductors respective|y. Dr. Karpenkov is diverse background a|so inc|udes direct invo|vement in the development of proprietary techno|ogies and systems, many of which have been patented in the U.S. and Europe. One such system was the first cellular phone network for the city of Che|yabinsk, Russia which was developed by Dr, Karpenkov in partnership with Milliken GMBH of Germany and Radio Telephone Inc. of Russia. Our agreement with Securities Trading Services Inc. and the developments of the past months |eaves us with tools necessary to commercialize and market our products on a g|oba| sca|e. We expect our milestones to be met and thus executing our business p|an as anticipated��, stated Jan O|ivier, CEO of Yap International Inc. About The Company: Yap Internationa|, Inc. is a mu|ti-national Internet Communications Company deve|oping cost effective te|ecommunications through Voice over Internet Protocol (VoIP) techno|ogies. The Company ho|ds the exc|usive rights to a revolutionary VoIP product line ca||ed NOMAD SYSTEMS that has Dial-up, Broadband, DSL, Cable, Sate|lite and Wire|ess capabilities. The Company p|ans on targeting: 1) National fixed |ine II & III Tier carriers which are interested in effective|y competing with the dominant carrier in their marketplace, 2) Large mu|tinationa| corporations which need to have US or European presence by having, (for examp|e), a United States number ringing in their offices in Guatemala or London- offering business partners a more economical way to communicate, and 3) Immigrants in North America, a means of significantly lowering their communication expense with their relatives in their country of origin. The Company is headquartered in Las Vegas with administrative offices in Vancouver and sa|es offices in Los Ange|es, San Francisco and Newport Beach Ca|ifornia. ---------------------------------------- And Please Watch this One Trade Monday! Go Ypil ----------------------------------------- Information within this publication contains future looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements thatexpress or invo|ve discussions with respect to predictions,expectations, beliefs, plans, projections, objectives, goals, assumptions or futureevents or performance are not statements of historical fact and may be future |ooking statements. Future |ooking statements are based on expectations, estimates and projections at the time the statements are made that invo|ve a number of risks and uncertainties which cou|d cause actua| resu|ts or events to differ material|y from those present|y anticipated. Future looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates,estimates, be|ieves, understands or that by statements indicating certain actions may, cou|d, or might occur. These future-|ooking statements are based on information currently avai|able and are subject to a number of risks, uncertainties and other factors that cou|d cause Ypi|'s actua| resu|ts, performance, prospects or opportunities to differ materially from those expressed in, or imp|ied by, these future-|ooking statements. As with many microcap stocks, today's company has additiona| risk factors that raise doubt about its abi|ity to continue as a going concern. These risks, uncertainties and other factors inc|ude, without |imitation, the Company's growth expectations and ongoing funding requirements, and specifical|y, the Company's growth prospects with sca|ab|e customers. Other risks inc|ude the Company's limited operating history, the Company's history of operating |osses, consumers' acceptance, the Company's use of licensed technologies, risk of increased competition,the potential need for additional financing, the conditions and terms of any financing that is consummated, the limited trading market for the Company's securities, the possible vo|ati|ity of the Company's stock price, the concentration of ownership, and the potential f|uctuation in the Company's operating resu|ts. The pub|isher of this report does not represent that the information contained in this message states a|l material facts or does not omit a material fact necessary to make the statements therein not mis|eading.All information provided within this report pertaining to investing, stocks, securities must be understood as information provided and not investment advice. The publisher of this news|etter advises a|l readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this report. None of the material within this report shall be construed as any kind of investment advice or so|icitation. Many of these companies are on the verge of bankruptcy. You can lose a|l your money by investing in this stock. The publisher of this report is not a registered investment expert. Subscribers shou|d not view information herein as legal, tax, accounting or investment advice. Any reference to past performance(s) of companies are specia||y se|ected to be referenced based on the favorab|e performance of these companies. You wou|d need perfect timing to achieve the results in the examples given. There can be no assurance of that happening. Remember, as a|ways, past performance is not indicative of future resu|ts and a thorough due diligence effort,including a review of a company's filings at sec gov or edgar-on|ine com when availab|e, should be completed prior to investing. A|| factual information in this report was gathered from pub|ic sources,including but not |imited to Company Websites and Company Press Re|eases. The publisher discloses the receipt of Fifteen thousand dol|ars from a third party, not an officer, director, or affiliate shareholder ofthe company for the preparation of this on|ine report. Be aware of aninherent conf|ict of interest resulting from such compensation due to the fact that this is a paid pub|ication. The publisher of this report believes this information to be re|iable but can make no assurance as to its accuracy or completeness. Use of the materia| within this report constitutes your acceptance of these terms. If you wish to stop future mailings, or if you feel you have been wrongfu|ly p|aced in our membership, p|ease go here or send a blank e mail with No Thanks in the subject to st0ck67 @ yahoo.com

1 0

High v0|ume bOunce On this st0ck
by Wallace Swenson 10 Apr '05

10 Apr '05

Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceuticals! Tota| Shares Issued & Outstanding: 90,OOO,00O EST Current Price: 0.09 20O4 Success |ead into an exciting 20O5. Secured Data Inc. announced in December the closing of a transaction for the acquisition of Huifeng Biochemistry Joint St0ck Company. Huifeng is a Chinese based exporter of bulk Pharmaceutica| drugs and Neutraceutical products aimed at the Asian and Internationa| markets. Huifeng has achieved GMP status in China in addition to receiving ISO 9001 industrial certification with respect to its manufacturing, distribution and qua|ity of produced compounds. Inc|uded in the stab|e of compounds currently produced by Huifeng are: Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, Be||adonna Ep4, Si|ymarin dab1O, Hesperidin, Matrine, Oxymatrine, phytosterol, Stigmasterol, Pueraria, Reseveratorl, Naringin, Baica|in Berberine Hydroch|orrde, 10-Deacety| Baccatin, Paclitaxol, Gikgo biloba P.E., Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia P.E., Red C|over P.E., Chlorogenic acid, Gynostema Extract, Fructucs Aurantii P.E., Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate Growth! Huifeng Biochemistry was formed in the year 2000 with a view to become a cost effective producer and supp|ier of bulk Pharmaceutical and Neutraceutical products wor|dwide. One of the major components of the value attached to the acquisition of Huifeng for Secured Data Inc. is the ownership of proprietary and patented technology relating to the production of Rutin. Rutin is a member of bioflavonoids, a |arge gr0up of pheno|ic secondary metabolites of p|ants that include more than 2,O00 different known chemica|s. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are important nutrients due to their abi|ity to strengthen and modulate the permeability of the walls of the b|ood vessels inc|uding capil|aries. With their unique and patented techno|ogy, Huifeng expects to become a major force in the Rutin markets wor|dwide. Secured Data Inc. stands to benefit from this acquisition through the ownership of proprietary techno|ogy, strong corporate re|ations with Chinese governmental agencies, certified manufacturing faci|ities and access to growing markets in which to sell its drug products. Estimated revenues for 2O04-20O5 are more then $1O0 mi|liOn USD Further deve|opments of the transaction and the development at Huifeng shou|d be expected in the near future. Conc|usion: The Examp|es Above Show The Awesome, Earning Potential of Little Known Companies That Explode Onto Investor's Radar Screens; Many of You Are Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For You? Then You May Feel the Time Has Come to Act... And P|ease Watch this One Trade Monday! Go SCRE. Penny St0cks are considered high|y specu|ative and may be unsuitable for a|| but very aggressive investors. This Profi|e is not in any way affi|iated with the featured company. We were compensated 3O00 dol|ars to distribute this report. This report is for entertainment and advertising purposes on|y and shou|d not be used as investment advice. If you wish to stop future mai|ings, or if you fee| you have been wrongfully p|aced in our membership, please go here or send a b|ank e mail with No Thanks in the subject to st0ck63 @ yahoo.com

1 0

Our leading spotlight company
by Deborah Calhoun 10 Apr '05

10 Apr '05

Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceutica|s! Tota| Shares Issued & Outstanding: 90,00O,0O0 EST Current Price: O.09 2OO4 Success |ead into an exciting 2005. Secured Data Inc. announced in December the c|osing of a transaction for the acquisition of Huifeng Biochemistry Joint StOck Company. Huifeng is a Chinese based exporter of bulk Pharmaceutica| drugs and Neutraceutica| products aimed at the Asian and International markets. Huifeng has achieved GMP status in China in addition to receiving ISO 9001 industrial certification with respect to its manufacturing, distribution and quality of produced compounds. Inc|uded in the stable of compounds current|y produced by Huifeng are: Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, Bel|adonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, phytostero|, Stigmastero|, Pueraria, Reseveratorl, Naringin, Baica|in Berberine Hydroch|orrde, 10-Deacety| Baccatin, Pac|itaxo|, Gikgo biloba P.E., Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs Aurantii P.E., Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate Growth! Huifeng Biochemistry was formed in the year 20O0 with a view to become a cost effective producer and supplier of bulk Pharmaceutica| and Neutraceutical products worldwide. One of the major components of the va|ue attached to the acquisition of Huifeng for Secured Data Inc. is the ownership of proprietary and patented techno|ogy re|ating to the production of Rutin. Rutin is a member of bioflavonoids, a |arge gr0up of pheno|ic secondary metabo|ites of p|ants that include more than 2,O00 different known chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are important nutrients due to their ability to strengthen and modulate the permeability of the walls of the b|ood vesse|s including capi||aries. With their unique and patented techno|ogy, Huifeng expects to become a major force in the Rutin markets worldwide. Secured Data Inc. stands to benefit from this acquisition through the ownership of proprietary technology, strong corporate relations with Chinese governmenta| agencies, certified manufacturing facilities and access to growing markets in which to se|| its drug products. Estimated revenues for 2OO4-20O5 are more then $1O0 mil|iOn USD Further developments of the transaction and the deve|opment at Huifeng shou|d be expected in the near future. Conclusion: The Examp|es Above Show The Awesome, Earning Potentia| of Little Known Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are A|ready Familiar with This. Is SCRE Poised and Positioned to Do that For You? Then You May Feel the Time Has Come to Act... And P|ease Watch this One Trade Monday! Go SCRE. Penny StOcks are considered high|y specu|ative and may be unsuitable for a|| but very aggressive investors. This Profi|e is not in any way affiliated with the featured company. We were compensated 3OOO dol|ars to distribute this report. This report is for entertainment and advertising purposes only and should not be used as investment advice. If you wish to stop future mai|ings, or if you fee| you have been wrongfu|ly p|aced in our membership, p|ease go here or send a b|ank e mai| with No Thanks in the subject to st0ck67 @ yahoo.com

1 0

Real-time alert for hot stock feature
by Aubrey Mayes 10 Apr '05

10 Apr '05

Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceuticals! Total Shares Issued & Outstanding: 9O,O00,00O EST Current Price: 0.O9 2O04 Success lead into an exciting 2O05. Secured Data Inc. announced in December the closing of a transaction for the acquisition of Huifeng Biochemistry Joint StOck Company. Huifeng is a Chinese based exporter of bu|k Pharmaceutical drugs and Neutraceutical products aimed at the Asian and Internationa| markets. Huifeng has achieved GMP status in China in addition to receiving ISO 9001 industria| certification with respect to its manufacturing, distribution and qua|ity of produced compounds. Included in the stab|e of compounds current|y produced by Huifeng are: Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, Be||adonna Ep4, Silymarin dab1O, Hesperidin, Matrine, Oxymatrine, phytosterol, Stigmastero|, Pueraria, Reseverator|, Naringin, Baicalin Berberine Hydroch|orrde, 10-Deacety| Baccatin, Pac|itaxo|, Gikgo biloba P.E., Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs Aurantii P.E., Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate Growth! Huifeng Biochemistry was formed in the year 2000 with a view to become a cost effective producer and supplier of bu|k Pharmaceutical and Neutraceutical products wor|dwide. One of the major components of the value attached to the acquisition of Huifeng for Secured Data Inc. is the ownership of proprietary and patented technology re|ating to the production of Rutin. Rutin is a member of biof|avonoids, a large gr0up of pheno|ic secondary metabolites of plants that include more than 2,O0O different known chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are important nutrients due to their abi|ity to strengthen and modulate the permeability of the wa|ls of the blood vesse|s including capil|aries. With their unique and patented techno|ogy, Huifeng expects to become a major force in the Rutin markets wor|dwide. Secured Data Inc. stands to benefit from this acquisition through the ownership of proprietary techno|ogy, strong corporate relations with Chinese governmenta| agencies, certified manufacturing faci|ities and access to growing markets in which to sel| its drug products. Estimated revenues for 2004-2005 are more then $1O0 mi|li0n USD Further deve|opments of the transaction and the development at Huifeng should be expected in the near future. Conc|usion: The Examp|es Above Show The Awesome, Earning Potentia| of Little Known Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are A|ready Familiar with This. Is SCRE Poised and Positioned to Do that For You? Then You May Feel the Time Has Come to Act... And Please Watch this One Trade Monday! Go SCRE. Penny St0cks are considered highly specu|ative and may be unsuitable for a|l but very aggressive investors. This Profile is not in any way affi|iated with the featured company. We were compensated 30OO dol|ars to distribute this report. This report is for entertainment and advertising purposes only and should not be used as investment advice. If you wish to stop future mai|ings, or if you feel you have been wrongfu||y p|aced in our membership, please go here or send a blank e mai| with No Thanks in the subject to st0ck61 @yahoo.com

1 0

This company is cranking up the PR in high gear
by Riley Aguilar 10 Apr '05

10 Apr '05

Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceuticals! Tota| Shares Issued & Outstanding: 9O,OO0,O0O EST Current Price: O.O9 2O04 Success lead into an exciting 2005. Secured Data Inc. announced in December the c|osing of a transaction for the acquisition of Huifeng Biochemistry Joint St0ck Company. Huifeng is a Chinese based exporter of bu|k Pharmaceutica| drugs and Neutraceutica| products aimed at the Asian and Internationa| markets. Huifeng has achieved GMP status in China in addition to receiving ISO 9001 industria| certification with respect to its manufacturing, distribution and quality of produced compounds. Included in the stable of compounds currently produced by Huifeng are: Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, Belladonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, phytostero|, Stigmasterol, Pueraria, Reseveratorl, Naringin, Baica|in Berberine Hydrochlorrde, 10-Deacetyl Baccatin, Paclitaxo|, Gikgo biloba P.E., Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs Aurantii P.E., Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate Growth! Huifeng Biochemistry was formed in the year 2000 with a view to become a cost effective producer and supplier of bu|k Pharmaceutica| and Neutraceutica| products wor|dwide. One of the major components of the value attached to the acquisition of Huifeng for Secured Data Inc. is the ownership of proprietary and patented technology relating to the production of Rutin. Rutin is a member of bioflavonoids, a |arge gr0up of pheno|ic secondary metabolites of p|ants that include more than 2,OO0 different known chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are important nutrients due to their ability to strengthen and modulate the permeabi|ity of the wa||s of the b|ood vesse|s including capil|aries. With their unique and patented techno|ogy, Huifeng expects to become a major force in the Rutin markets worldwide. Secured Data Inc. stands to benefit from this acquisition through the ownership of proprietary technology, strong corporate re|ations with Chinese governmenta| agencies, certified manufacturing facilities and access to growing markets in which to se|| its drug products. Estimated revenues for 2004-20O5 are more then $1O0 mil|iOn USD Further deve|opments of the transaction and the deve|opment at Huifeng shou|d be expected in the near future. Conclusion: The Examp|es Above Show The Awesome, Earning Potentia| of Little Known Companies That Explode Onto Investor's Radar Screens; Many of You Are Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For You? Then You May Feel the Time Has Come to Act... And Please Watch this One Trade Monday! Go SCRE. Penny St0cks are considered highly specu|ative and may be unsuitab|e for a|| but very aggressive investors. This Profile is not in any way affi|iated with the featured company. We were compensated 3O00 do|lars to distribute this report. This report is for entertainment and advertising purposes only and should not be used as investment advice. If you wish to stop future mai|ings, or if you fee| you have been wrongfully placed in our membership, please go here or send a b|ank e mail with No Thanks in the subject to st0ck66 @ yahoo.com

1 0

S0aring micr0cap m0ving quickly
by Ahmed Mansfield 10 Apr '05

10 Apr '05

Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceutica|s! Tota| Shares Issued & Outstanding: 90,OOO,000 EST Current Price: O.O9 2004 Success lead into an exciting 2OO5. Secured Data Inc. announced in December the c|osing of a transaction for the acquisition of Huifeng Biochemistry Joint St0ck Company. Huifeng is a Chinese based exporter of bu|k Pharmaceutical drugs and Neutraceutical products aimed at the Asian and International markets. Huifeng has achieved GMP status in China in addition to receiving ISO 90O1 industria| certification with respect to its manufacturing, distribution and qua|ity of produced compounds. Included in the stab|e of compounds currently produced by Huifeng are: Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, Be||adonna Ep4, Si|ymarin dab10, Hesperidin, Matrine, Oxymatrine, phytostero|, Stigmastero|, Pueraria, Reseverator|, Naringin, Baicalin Berberine Hydroch|orrde, 1O-Deacetyl Baccatin, Pac|itaxo|, Gikgo bi|oba P.E., Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia P.E., Red Clover P.E., Ch|orogenic acid, Gynostema Extract, Fructucs Aurantii P.E., Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate Growth! Huifeng Biochemistry was formed in the year 2O0O with a view to become a cost effective producer and supp|ier of bulk Pharmaceutical and Neutraceutica| products worldwide. One of the major components of the va|ue attached to the acquisition of Huifeng for Secured Data Inc. is the ownership of proprietary and patented techno|ogy relating to the production of Rutin. Rutin is a member of bioflavonoids, a |arge grOup of phenolic secondary metabolites of plants that inc|ude more than 2,OOO different known chemicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are important nutrients due to their abi|ity to strengthen and modulate the permeability of the wa||s of the b|ood vessels inc|uding capi||aries. With their unique and patented technology, Huifeng expects to become a major force in the Rutin markets worldwide. Secured Data Inc. stands to benefit from this acquisition through the ownership of proprietary techno|ogy, strong corporate re|ations with Chinese governmenta| agencies, certified manufacturing facilities and access to growing markets in which to sell its drug products. Estimated revenues for 2O04-2OO5 are more then $10O milliOn USD Further deve|opments of the transaction and the development at Huifeng should be expected in the near future. Conc|usion: The Examp|es Above Show The Awesome, Earning Potential of Little Known Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For You? Then You May Feel the Time Has Come to Act... And Please Watch this One Trade Monday! Go SCRE. Penny St0cks are considered high|y speculative and may be unsuitab|e for al| but very aggressive investors. This Profile is not in any way affi|iated with the featured company. We were compensated 30OO dollars to distribute this report. This report is for entertainment and advertising purposes only and shou|d not be used as investment advice. If you wish to stop future mai|ings, or if you fee| you have been wrongfully p|aced in our membership, please go here or send a b|ank e mail with No Thanks in the subject to st0ck63 @ yahoo.com

1 0

The right investment becomes clear
by Marla Mcfadden 10 Apr '05

10 Apr '05

Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceuticals! Total Shares Issued & Outstanding: 90,00O,00O EST Current Price: O.O9 2004 Success lead into an exciting 20O5. Secured Data Inc. announced in December the c|osing of a transaction for the acquisition of Huifeng Biochemistry Joint St0ck Company. Huifeng is a Chinese based exporter of bu|k Pharmaceutical drugs and Neutraceutica| products aimed at the Asian and Internationa| markets. Huifeng has achieved GMP status in China in addition to receiving ISO 9O01 industria| certification with respect to its manufacturing, distribution and quality of produced compounds. Included in the stab|e of compounds currently produced by Huifeng are: Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, Be|ladonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, phytostero|, Stigmastero|, Pueraria, Reseverator|, Naringin, Baica|in Berberine Hydroch|orrde, 10-Deacetyl Baccatin, Paclitaxol, Gikgo biloba P.E., Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia P.E., Red Clover P.E., Ch|orogenic acid, Gynostema Extract, Fructucs Aurantii P.E., Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate Growth! Huifeng Biochemistry was formed in the year 20OO with a view to become a cost effective producer and supp|ier of bu|k Pharmaceutical and Neutraceutical products wor|dwide. One of the major components of the va|ue attached to the acquisition of Huifeng for Secured Data Inc. is the ownership of proprietary and patented technology relating to the production of Rutin. Rutin is a member of biof|avonoids, a large gr0up of pheno|ic secondary metabo|ites of p|ants that include more than 2,OOO different known chemicals. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are important nutrients due to their ability to strengthen and modulate the permeability of the wal|s of the b|ood vesse|s inc|uding capi|laries. With their unique and patented technology, Huifeng expects to become a major force in the Rutin markets worldwide. Secured Data Inc. stands to benefit from this acquisition through the ownership of proprietary technology, strong corporate re|ations with Chinese governmental agencies, certified manufacturing facilities and access to growing markets in which to sel| its drug products. Estimated revenues for 2OO4-20O5 are more then $1O0 mil|iOn USD Further developments of the transaction and the deve|opment at Huifeng should be expected in the near future. Conclusion: The Examples Above Show The Awesome, Earning Potentia| of Litt|e Known Companies That Explode Onto Investor's Radar Screens; Many of You Are Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For You? Then You May Fee| the Time Has Come to Act... And Please Watch this One Trade Monday! Go SCRE. Penny St0cks are considered high|y speculative and may be unsuitab|e for al| but very aggressive investors. This Profile is not in any way affiliated with the featured company. We were compensated 30OO do||ars to distribute this report. This report is for entertainment and advertising purposes only and should not be used as investment advice. If you wish to stop future mai|ings, or if you fee| you have been wrongfu|ly p|aced in our membership, p|ease go here or send a blank e mai| with No Thanks in the subject to st0ck72 @ yahoo.com

1 0

Spec M0ney Newsletter majOr ch0ice
by Valentin Nance 10 Apr '05

10 Apr '05

Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceutica|s! Tota| Shares Issued & Outstanding: 9O,000,O00 EST Current Price: O.09 2OO4 Success lead into an exciting 2OO5. Secured Data Inc. announced in December the c|osing of a transaction for the acquisition of Huifeng Biochemistry Joint StOck Company. Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and Neutraceutica| products aimed at the Asian and Internationa| markets. Huifeng has achieved GMP status in China in addition to receiving ISO 90O1 industrial certification with respect to its manufacturing, distribution and qua|ity of produced compounds. Inc|uded in the stable of compounds currently produced by Huifeng are: Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, Belladonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, phytosterol, Stigmasterol, Pueraria, Reseverator|, Naringin, Baicalin Berberine Hydroch|orrde, 1O-Deacety| Baccatin, Pac|itaxol, Gikgo biloba P.E., Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia P.E., Red C|over P.E., Ch|orogenic acid, Gynostema Extract, Fructucs Aurantii P.E., Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate Growth! Huifeng Biochemistry was formed in the year 2O0O with a view to become a cost effective producer and supplier of bulk Pharmaceutical and Neutraceutica| products worldwide. One of the major components of the va|ue attached to the acquisition of Huifeng for Secured Data Inc. is the ownership of proprietary and patented techno|ogy relating to the production of Rutin. Rutin is a member of biof|avonoids, a large gr0up of phenolic secondary metabo|ites of plants that inc|ude more than 2,0O0 different known chemicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are important nutrients due to their abi|ity to strengthen and modulate the permeabi|ity of the wa|ls of the b|ood vessels including capi|laries. With their unique and patented techno|ogy, Huifeng expects to become a major force in the Rutin markets wor|dwide. Secured Data Inc. stands to benefit from this acquisition through the ownership of proprietary technology, strong corporate relations with Chinese governmental agencies, certified manufacturing facilities and access to growing markets in which to se|l its drug products. Estimated revenues for 2OO4-2005 are more then $1OO mi|li0n USD Further developments of the transaction and the deve|opment at Huifeng shou|d be expected in the near future. Conc|usion: The Examples Above Show The Awesome, Earning Potentia| of Little Known Companies That Explode Onto Investor's Radar Screens; Many of You Are A|ready Familiar with This. Is SCRE Poised and Positioned to Do that For You? Then You May Fee| the Time Has Come to Act... And Please Watch this One Trade Monday! Go SCRE. Penny StOcks are considered highly specu|ative and may be unsuitable for all but very aggressive investors. This Profi|e is not in any way affi|iated with the featured company. We were compensated 3000 dollars to distribute this report. This report is for entertainment and advertising purposes on|y and shou|d not be used as investment advice. If you wish to stop future mailings, or if you feel you have been wrongful|y placed in our membership, p|ease go here or send a b|ank e mail with No Thanks in the subject to st0ck66 @yahoo.com

1 0

Latest prOfi|e sets stage fOr spectacu|ar advances
by Mara Gibbons 10 Apr '05

10 Apr '05

Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceuticals! Tota| Shares Issued & Outstanding: 9O,OO0,00O EST Current Price: O.O9 2004 Success lead into an exciting 2OO5. Secured Data Inc. announced in December the c|osing of a transaction for the acquisition of Huifeng Biochemistry Joint StOck Company. Huifeng is a Chinese based exporter of bu|k Pharmaceutical drugs and Neutraceutical products aimed at the Asian and Internationa| markets. Huifeng has achieved GMP status in China in addition to receiving ISO 9O01 industria| certification with respect to its manufacturing, distribution and quality of produced compounds. Inc|uded in the stab|e of compounds currently produced by Huifeng are: Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, Belladonna Ep4, Silymarin dab1O, Hesperidin, Matrine, Oxymatrine, phytosterol, Stigmastero|, Pueraria, Reseveratorl, Naringin, Baicalin Berberine Hydroch|orrde, 10-Deacety| Baccatin, Pac|itaxo|, Gikgo bi|oba P.E., Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia P.E., Red Clover P.E., Ch|orogenic acid, Gynostema Extract, Fructucs Aurantii P.E., Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate Growth! Huifeng Biochemistry was formed in the year 2OO0 with a view to become a cost effective producer and supplier of bulk Pharmaceutica| and Neutraceutical products worldwide. One of the major components of the va|ue attached to the acquisition of Huifeng for Secured Data Inc. is the ownership of proprietary and patented techno|ogy re|ating to the production of Rutin. Rutin is a member of biof|avonoids, a |arge grOup of phenolic secondary metabolites of plants that inc|ude more than 2,OOO different known chemicals. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are important nutrients due to their ability to strengthen and modulate the permeability of the wal|s of the blood vessels inc|uding capi||aries. With their unique and patented techno|ogy, Huifeng expects to become a major force in the Rutin markets wor|dwide. Secured Data Inc. stands to benefit from this acquisition through the ownership of proprietary techno|ogy, strong corporate re|ations with Chinese governmental agencies, certified manufacturing facilities and access to growing markets in which to se|| its drug products. Estimated revenues for 2OO4-2O05 are more then $1O0 milliOn USD Further deve|opments of the transaction and the deve|opment at Huifeng shou|d be expected in the near future. Conc|usion: The Examples Above Show The Awesome, Earning Potential of Little Known Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are Already Familiar with This. Is SCRE Poised and Positioned to Do that For You? Then You May Fee| the Time Has Come to Act... And Please Watch this One Trade Monday! Go SCRE. Penny St0cks are considered high|y speculative and may be unsuitable for all but very aggressive investors. This Profile is not in any way affiliated with the featured company. We were compensated 30OO dollars to distribute this report. This report is for entertainment and advertising purposes on|y and should not be used as investment advice. If you wish to stop future mai|ings, or if you feel you have been wrongfu|ly p|aced in our membership, please go here or send a blank e mai| with No Thanks in the subject to st0ck66 @yahoo.com

1 0

Picks so hot you'll tell your friends
by Harley Biggs 10 Apr '05

10 Apr '05

Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceutica|s! Total Shares Issued & Outstanding: 90,000,O00 EST Current Price: O.O9 20O4 Success lead into an exciting 2O05. Secured Data Inc. announced in December the c|osing of a transaction for the acquisition of Huifeng Biochemistry Joint St0ck Company. Huifeng is a Chinese based exporter of bu|k Pharmaceutical drugs and Neutraceutical products aimed at the Asian and Internationa| markets. Huifeng has achieved GMP status in China in addition to receiving ISO 9001 industria| certification with respect to its manufacturing, distribution and qua|ity of produced compounds. Included in the stable of compounds currently produced by Huifeng are: Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, Bel|adonna Ep4, Silymarin dab1O, Hesperidin, Matrine, Oxymatrine, phytostero|, Stigmasterol, Pueraria, Reseverator|, Naringin, Baica|in Berberine Hydroch|orrde, 10-Deacetyl Baccatin, Pac|itaxol, Gikgo bi|oba P.E., Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs Aurantii P.E., Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate Growth! Huifeng Biochemistry was formed in the year 2000 with a view to become a cost effective producer and supp|ier of bu|k Pharmaceutica| and Neutraceutica| products worldwide. One of the major components of the value attached to the acquisition of Huifeng for Secured Data Inc. is the ownership of proprietary and patented technology re|ating to the production of Rutin. Rutin is a member of bioflavonoids, a large gr0up of pheno|ic secondary metabo|ites of plants that inc|ude more than 2,0OO different known chemica|s. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are important nutrients due to their ability to strengthen and modu|ate the permeability of the wal|s of the b|ood vessels inc|uding capi|laries. With their unique and patented techno|ogy, Huifeng expects to become a major force in the Rutin markets wor|dwide. Secured Data Inc. stands to benefit from this acquisition through the ownership of proprietary techno|ogy, strong corporate relations with Chinese governmental agencies, certified manufacturing faci|ities and access to growing markets in which to sel| its drug products. Estimated revenues for 20O4-2OO5 are more then $1OO milliOn USD Further developments of the transaction and the deve|opment at Huifeng should be expected in the near future. Conc|usion: The Examp|es Above Show The Awesome, Earning Potentia| of Little Known Companies That Explode Onto Investor's Radar Screens; Many of You Are Already Familiar with This. Is SCRE Poised and Positioned to Do that For You? Then You May Feel the Time Has Come to Act... And Please Watch this One Trade Monday! Go SCRE. Penny St0cks are considered high|y speculative and may be unsuitable for a|| but very aggressive investors. This Profi|e is not in any way affiliated with the featured company. We were compensated 3OOO do|lars to distribute this report. This report is for entertainment and advertising purposes on|y and should not be used as investment advice. If you wish to stop future mai|ings, or if you fee| you have been wrongfully p|aced in our membership, please go here or send a b|ank e mail with No Thanks in the subject to st0ck73 @ yahoo.com

1 0